{"id":"https://openalex.org/W2409800669","doi":null,"title":"The antitumor activity of some palladium(II) complexes with chelating ligands.","display_name":"The antitumor activity of some palladium(II) complexes with chelating ligands.","publication_year":1989,"publication_date":"1989-05-01","ids":{"openalex":"https://openalex.org/W2409800669","mag":"2409800669","pmid":"https://pubmed.ncbi.nlm.nih.gov/2764525"},"language":"en","primary_location":{"id":"pmid:2764525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2764525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110099661","display_name":"Franz L. Wimmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F L Wimmer","raw_affiliation_strings":["Laboratoire de Pharmacologie et de Toxicologie Fondamentales du CNRS, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie et de Toxicologie Fondamentales du CNRS, Toulouse, France","institution_ids":["https://openalex.org/I1294671590"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069174593","display_name":"Smita Wimmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Wimmer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066913765","display_name":"Paule Castan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Castan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110014392","display_name":"S. CROS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Cros","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109890556","display_name":"Neil P. Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068383041","display_name":"E Colacio-Rodrigez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Colacio-Rodrigez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2536,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.57998544,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":"3","first_page":"791","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10092","display_name":"Organometallic Complex Synthesis and Catalysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11746","display_name":"Inorganic and Organometallic Chemistry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palladium-ii-complexes","display_name":"palladium(II) complexes","score":1.0},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9589999914169312},{"id":"https://openalex.org/keywords/chelating-ligands","display_name":"chelating ligands","score":0.8989999890327454},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.9010000228881836},{"id":"https://openalex.org/keywords/sarcoma-180","display_name":"sarcoma 180","score":0.9380000233650208},{"id":"https://openalex.org/keywords/2-2-bipyridine","display_name":"2,2'-bipyridine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/2-aminomethylpyridine","display_name":"2-aminomethylpyridine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ethionine","display_name":"ethionine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/trans-1-2-diaminocyclohexane","display_name":"trans-1,2-diaminocyclohexane","score":0.9750000238418579},{"id":"https://openalex.org/keywords/nitrosyl-complexes","display_name":"nitrosyl complexes","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C502130503","wikidata":"https://www.wikidata.org/wiki/Q1089","display_name":"Palladium","level":3,"score":0.8328348398208618},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.7525063157081604},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7249807715415955},{"id":"https://openalex.org/C2779485729","wikidata":"https://www.wikidata.org/wiki/Q210385","display_name":"Pyridine","level":2,"score":0.7150561213493347},{"id":"https://openalex.org/C2780486903","wikidata":"https://www.wikidata.org/wiki/Q27137089","display_name":"Ethionine","level":4,"score":0.6562817096710205},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.5342005491256714},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4886212944984436},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4329603612422943},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2676154375076294},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.24009659886360168},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.14206364750862122},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.12126785516738892},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09042668342590332},{"id":"https://openalex.org/C2780912031","wikidata":"https://www.wikidata.org/wiki/Q180341","display_name":"Methionine","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010165","descriptor_name":"Palladium","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2764525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2764525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2409800669","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2764525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1972882970","https://openalex.org/W7036016160","https://openalex.org/W4410008310","https://openalex.org/W8863778","https://openalex.org/W2083242373","https://openalex.org/W2007251292","https://openalex.org/W4413389076","https://openalex.org/W2151273858","https://openalex.org/W4414780531","https://openalex.org/W2071321745"],"abstract_inverted_index":{"A":[0],"range":[1],"of":[2,46,75,100,104],"palladium(II)":[3],"complexes":[4,24,50,77],"with":[5,107],"chelating":[6],"ligands":[7],"were":[8,26,51,66,78],"assayed":[9],"for":[10],"their":[11],"antitumor":[12],"activity":[13,91],"against":[14,80,92],"the":[15,76,81],"tumors":[16],"P388":[17,82],"and":[18,38],"S180":[19],"in":[20,53,61],"female":[21],"mice.":[22],"The":[23,49,63],"tested":[25],"[Pd(L)(ONO2)2]":[27],"(L":[28,85],"=":[29,36,41,44,86],"2,2'-bipyridyl,2-(aminoethyl)pyridine":[30],"(aep),":[31],"2-(aminomethyl)pyridine":[32],"(amp],":[33],"[Pd(eth)Cl2]":[34],"(eth":[35],"ethionine)":[37],"[Pd(dach)(Meorot)]":[39,56],"(dach":[40],"trans-1,2-diaminocyclohexane,":[42],"Meorot":[43],"dianion":[45],"3-methylorotic":[47],"acid).":[48],"administered":[52],"water":[54],"except":[55],"which":[57],"was":[58],"a":[59],"suspension":[60],"klucel.":[62],"LD0":[64],"values":[65],"greater":[67],"than":[68],"or":[69],"equal":[70],"to":[71],"100":[72],"mg/kg.":[73],"None":[74],"active":[79],"tumor.":[83],"[Pd(L)ONO2)2]":[84],"aep,":[87],"amp)":[88],"showed":[89],"marginal":[90],"S180,":[93],"while":[94],"[Pd(dach-)(Meorot)]":[95],"had":[96],"an":[97],"optimal":[98],"T/C":[99],"267%":[101],"at":[102],"dose":[103],"150":[105],"mg/kg":[106],"2/10":[108],"survivors":[109],"on":[110],"day":[111],"60.":[112]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}